Under the agreement, Synthes will work with Kuros to commercialize Kuros' synthetic matrix technology in certain fields. The partnership allows both companies to expand strategic presence in certain medical device fields.
More Articles on Orthopedic Devices:
US Implantable Medical Devices Demand to Increase 7.7% Annually Through 2015
Exactech's Deferred Prosecution Agreement Expires
BioMimetic Reports 2011 Revenue
Synthes Signs Licensing Agreement With KurosWritten by Laura Miller | March 20, 2012
Synthes announced it signed a license and development agreement with Kuros to commercialize Kuros' synthetic matrix technology.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.